Mu He

Assistant Professor @HKUniversity @hkumed School of Biomedical Sciences. By way of @sloan_kettering and @UCSF. Tissue development and regeneration

[valentina greco @valentatormenta]

The #ISSCR2025 program covers global breadth of stem cell research and regenerative medicine with 70% of the invited speakers as first-time ISSCR speakers. Grateful to the program committee, co-chairs Eugenia Piddini and Kathy Cheah and the ISSCR team https://t.co/5irL3r6KQO

[GRC_Cilia_Mucus_2025 @GRC_CMM]

Join us for GRC Cilia, Mucus and Mucociliary Interactions in Pomona, CA 16-21 February 2025! An amazing line-up of established & emerging leaders in this interdisciplinary field- >15 podium talk slots to share your work. /1
#cilia #mucus #genetics #CellBiology #biophysics

[Mu He @Hippo326]

Good morning Dublin 🤩 what time exactly do we start the first session #cilia2024

[Mu He @Hippo326]

@JingHughes Thank you, Jing, for being a great host!

[Stella Hurtley @SMHSci]

https://t.co/Yr1ijAMruB

[Kirsty Wan 🔬 @micromotility]

📢Don't miss this chance to join @LSI_Exeter for a unique way of doing interdisciplinary science!
Currently recruiting (open rank) 3 people with research aligned with biology/biomedicine
https://t.co/vdqnMscRMg
(feel free to reach out to me if you have any questions)

[X David Li Lab @XDavidLiLab1]

Reunion of Kapoor lab @KapoorLab_RU alumni @JeffTiLab @XDavidLiLab1 and collaborator @Hippo326 for hotpot in Hong Kong😁

[Mu He @Hippo326]

@JingHughes Thanks for visiting me in HK, Jing! So good to see you😘😘

[Mu He @Hippo326]

@Loom19321 Congratulations Shu-Hsien! See you in north cal next time!

[Mu He @Hippo326]

Fantastic collaborative work on gain-of-function Ano1 variants and moyamoya disease! It begs the question: are Ano1 activators good options to treat #cysticfibrosis or asthma?

[Wenlei @peter_leaf]

Using human genetics, brain imaging, electrophysiology, and structural biology, we establish the association between Ca2+-activated Cl- channel (ANO1) with a progressive cerebrovascular arteriopathy, namely moyamoya disease (MMD). Great thanks to all the participants!

[Mu He @Hippo326]

this is the Hong Kong team 👈@metricausa @naturemethods https://t.co/YXDTzlpXK6

[X David Li Lab @XDavidLiLab1]

I would like to share with you our new work on the identification of the first bona fide 'reader' of #histone H3K79 methylation, which has been a mystery since the discovery of this modification in 2002.
https://t.co/xPfNz2VQTg
today online in @ScienceMagazine

[Mu He @Hippo326]

@alexmsci Congratulations Alex!

[X David Li Lab @XDavidLiLab1]

I would like to share with you our new work on the identification of the first bona fide 'reader' of #histone H3K79 methylation, which has been a mystery since the discovery of this modification in 2002.
https://t.co/xPfNz2VQTg
today online in @ScienceMagazine

[Mu He @Hippo326]

@lab_cao It does like make things up. It’s not just you!

[Mu He @Hippo326]

@alexmsci Congratulations Alex!

[Mu He @Hippo326]

@Mill_lab Yes! See you in a few months 😍

[Mu He @Hippo326]

@Mill_lab Brilliant work! Looking forward to a deep read with my lab 🤩🤩Congratulations!

[Jiefu Li @JiefuBiol]

We are hiring! Join us @HHMIJanelia 🧑🏽‍🔬

[Mu He @Hippo326]

@MSYHuen Must be the jet lag🤩

[Mu He @Hippo326]

@Myers_lab @NatureSMB Beautiful work - Congratulations Ben & Co. !!